Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (1) Blankenstein, Thomas Prof. Dr. (28) Daniel, Peter Prof. Dr. (1) Ittermann, Bernd Dr. (1) Kammertöns, Thomas Dr. (6) Kettenmann, Helmut Prof. Dr. (2) Ku, Min-Chi Dr. (2) Leisegang, Matthias Dr. (1) Millward, Jason Dr. (1) Niendorf, Thoralf Prof. Dr. (29) Paul, Friedemann Prof. Dr. med. (2) Pezzutto, Antonio Prof. Dr. (2) Qadri, Fatimunnisa Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (10) Uckert, Wolfgang Prof. Dr. (3) Waiczies, Helmar Dr. (8) Waiczies, Sonia Dr. (8) Winter, Lukas Dr. (4) Wolf, Susanne Dr. (2) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (2) (-) Willimsky, Gerald Dr. (11) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) (-) 2010 (4) 2011 (2) 2012 (2) (-) 2013 (6) 2014 (2) 2015 (5) 2016 (5) 2017 (4) 2018 (7) 2019 (3) 2020 (4) 2021 (1) 2022 (9) Developmental Biology / Signal Transduction (1) (-) Experimental Ultrahigh-Field MR (1) Genetics, Nephrology, Hypertension, and Vascular Injury (1) Genetics of Metabolic and Reproductive Disorders (2) Molecular Cell Biology and Gene Therapy (2) (-) Molecular Immunology and Gene Therapy (12) Signal Transduction in Development and Cancer (1) 13 Results: Active Filter: Bunse, Mario Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.Experimental Ultrahigh-Field MRMolecular Immunology and Gene Therapy2002200720102013 Sort: Result score Newest to oldest Oldest to newest August 01, 2013 in Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder April 22, 2013 in PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf March 07, 2013 in Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky March 01, 2013 in J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein February 08, 2013 in Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel February 05, 2013 in Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein December 16, 2010 in Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein September 01, 2010 in Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler March 15, 2010 in J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein March 01, 2010 in Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel Pagination Current page 1 Page 2 Next page Next › Last page Last »
August 01, 2013 in Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
April 22, 2013 in PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf
March 07, 2013 in Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
March 01, 2013 in J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
February 08, 2013 in Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
February 05, 2013 in Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
December 16, 2010 in Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
September 01, 2010 in Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler
March 15, 2010 in J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
March 01, 2010 in Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
